However, in the analysis of axillary lymph node tumor burden, we found that in the luminal A type, HER-2 overexpression type, and triple-negative breast cancer, the proportion of patients with a mild lymph node tumor burden was significantly higher than that of patients with a heavy lymph node tumor burden. Here, ERBB2 is linked to triple-negative breast carcinoma.